Logo image of SHL.DE

SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:SHL - DE000SHL1006 - Common Stock

43.51 EUR
+0.82 (+1.92%)
Last: 12/5/2025, 7:00:00 PM
Fundamental Rating

5

Overall SHL gets a fundamental rating of 5 out of 10. We evaluated SHL against 63 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of SHL while its profitability can be described as average. SHL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SHL was profitable.
SHL had a positive operating cash flow in the past year.
Each year in the past 5 years SHL has been profitable.
In the past 5 years SHL always reported a positive cash flow from operatings.
SHL.DE Yearly Net Income VS EBIT VS OCF VS FCFSHL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.83%, SHL is in the better half of the industry, outperforming 62.12% of the companies in the same industry.
The Return On Equity of SHL (11.88%) is better than 66.67% of its industry peers.
With a decent Return On Invested Capital value of 7.65%, SHL is doing good in the industry, outperforming 60.61% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SHL is below the industry average of 9.81%.
The 3 year average ROIC (6.28%) for SHL is below the current ROIC(7.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.83%
ROE 11.88%
ROIC 7.65%
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
SHL.DE Yearly ROA, ROE, ROICSHL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

SHL's Profit Margin of 9.17% is fine compared to the rest of the industry. SHL outperforms 63.64% of its industry peers.
In the last couple of years the Profit Margin of SHL has remained more or less at the same level.
SHL has a better Operating Margin (13.53%) than 60.61% of its industry peers.
In the last couple of years the Operating Margin of SHL has remained more or less at the same level.
With a Gross Margin value of 38.63%, SHL is not doing good in the industry: 78.79% of the companies in the same industry are doing better.
SHL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.53%
PM (TTM) 9.17%
GM 38.63%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
SHL.DE Yearly Profit, Operating, Gross MarginsSHL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SHL is creating some value.
SHL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SHL has been increased compared to 5 years ago.
The debt/assets ratio for SHL has been reduced compared to a year ago.
SHL.DE Yearly Shares OutstandingSHL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SHL.DE Yearly Total Debt VS Total AssetsSHL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 2.02 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of SHL (2.02) is comparable to the rest of the industry.
SHL has a debt to FCF ratio of 5.45. This is a neutral value as SHL would need 5.45 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.45, SHL is in line with its industry, outperforming 53.03% of the companies in the same industry.
SHL has a Debt/Equity ratio of 0.63. This is a neutral value indicating SHL is somewhat dependend on debt financing.
SHL has a Debt to Equity ratio of 0.63. This is in the lower half of the industry: SHL underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 5.45
Altman-Z 2.02
ROIC/WACC1.2
WACC6.37%
SHL.DE Yearly LT Debt VS Equity VS FCFSHL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.11 indicates that SHL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.11, SHL is doing worse than 72.73% of the companies in the same industry.
A Quick Ratio of 0.79 indicates that SHL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.79, SHL is doing worse than 74.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.79
SHL.DE Yearly Current Assets VS Current LiabilitesSHL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.17% over the past year.
SHL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.29% yearly.
Looking at the last year, SHL shows a small growth in Revenue. The Revenue has grown by 4.53% in the last year.
SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.08% yearly.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%

3.2 Future

The Earnings Per Share is expected to grow by 8.79% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.85% on average over the next years.
EPS Next Y1.78%
EPS Next 2Y6.58%
EPS Next 3Y8.95%
EPS Next 5Y8.79%
Revenue Next Year3.08%
Revenue Next 2Y4.57%
Revenue Next 3Y5.17%
Revenue Next 5Y5.85%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SHL.DE Yearly Revenue VS EstimatesSHL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
SHL.DE Yearly EPS VS EstimatesSHL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.21, SHL is valued on the expensive side.
86.36% of the companies in the same industry are more expensive than SHL, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.49, SHL is valued a bit cheaper.
A Price/Forward Earnings ratio of 17.89 indicates a rather expensive valuation of SHL.
Based on the Price/Forward Earnings ratio, SHL is valued a bit cheaper than 63.64% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, SHL is valued a bit cheaper.
Industry RankSector Rank
PE 18.21
Fwd PE 17.89
SHL.DE Price Earnings VS Forward Price EarningsSHL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

63.64% of the companies in the same industry are more expensive than SHL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, SHL is valued cheaper than 86.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.08
EV/EBITDA 13.69
SHL.DE Per share dataSHL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SHL does not grow enough to justify the current Price/Earnings ratio.
SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)10.25
PEG (5Y)1.61
EPS Next 2Y6.58%
EPS Next 3Y8.95%

6

5. Dividend

5.1 Amount

SHL has a Yearly Dividend Yield of 2.34%.
SHL's Dividend Yield is rather good when compared to the industry average which is at 2.14. SHL pays more dividend than 81.82% of the companies in the same industry.
SHL's Dividend Yield is comparable with the S&P500 average which is at 2.31.
Industry RankSector Rank
Dividend Yield 2.34%

5.2 History

The dividend of SHL has a limited annual growth rate of 4.33%.
Dividend Growth(5Y)4.33%
Div Incr Years0
Div Non Decr Years6
SHL.DE Yearly Dividends per shareSHL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

SHL pays out 49.72% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.72%
EPS Next 2Y6.58%
EPS Next 3Y8.95%
SHL.DE Yearly Income VS Free CF VS DividendSHL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
SHL.DE Dividend Payout.SHL.DE Dividend Payout, showing the Payout Ratio.SHL.DE Dividend Payout.PayoutRetained Earnings

SIEMENS HEALTHINEERS AG

FRA:SHL (12/5/2025, 7:00:00 PM)

43.51

+0.82 (+1.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-05 2026-02-05
Inst Owners12.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap49.08B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts80
Price Target56.9 (30.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.34%
Yearly Dividend0.95
Dividend Growth(5Y)4.33%
DP49.72%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-6.13%
PT rev (3m)-8.05%
EPS NQ rev (1m)-8.32%
EPS NQ rev (3m)-8.32%
EPS NY rev (1m)-4.69%
EPS NY rev (3m)-7.09%
Revenue NQ rev (1m)1.66%
Revenue NQ rev (3m)1.66%
Revenue NY rev (1m)-1.1%
Revenue NY rev (3m)-1.45%
Valuation
Industry RankSector Rank
PE 18.21
Fwd PE 17.89
P/S 2.1
P/FCF 18.08
P/OCF 13.9
P/B 2.72
P/tB N/A
EV/EBITDA 13.69
EPS(TTM)2.39
EY5.49%
EPS(NY)2.43
Fwd EY5.59%
FCF(TTM)2.41
FCFY5.53%
OCF(TTM)3.13
OCFY7.2%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)10.25
PEG (5Y)1.61
Graham Number29.33
Profitability
Industry RankSector Rank
ROA 4.83%
ROE 11.88%
ROCE 9.97%
ROIC 7.65%
ROICexc 8.31%
ROICexgc 43.54%
OM 13.53%
PM (TTM) 9.17%
GM 38.63%
FCFM 11.61%
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.78%
ROICexc(5y)6.63%
ROICexgc(3y)34.62%
ROICexgc(5y)34.83%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y13.77%
ROICexgc growth 5Y12.12%
ROICexc growth 3Y9.41%
ROICexc growth 5Y-1.08%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 5.45
Debt/EBITDA 2.54
Cap/Depr 63.12%
Cap/Sales 3.5%
Interest Coverage 7.04
Cash Conversion 79.23%
Profit Quality 126.59%
Current Ratio 1.11
Quick Ratio 0.79
Altman-Z 2.02
F-Score8
WACC6.37%
ROIC/WACC1.2
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y1.78%
EPS Next 2Y6.58%
EPS Next 3Y8.95%
EPS Next 5Y8.79%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year3.08%
Revenue Next 2Y4.57%
Revenue Next 3Y5.17%
Revenue Next 5Y5.85%
EBIT growth 1Y12.53%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year35.66%
EBIT Next 3Y17.7%
EBIT Next 5Y14.23%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%

SIEMENS HEALTHINEERS AG / SHL.DE FAQ

What is the fundamental rating for SHL stock?

ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.


What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for SIEMENS HEALTHINEERS AG?

SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for SHL stock?

The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 18.21 and the Price/Book (PB) ratio is 2.72.


Can you provide the dividend sustainability for SHL stock?

The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.72%.